Human PBMC hold a vast amount of untapped information relevant to immunology, toxicology, inflammation, vaccination, and other areas of study related to the human immune response.

We’ve added to our growing list of disease-state PBMC with products collected from donors with a history of SARS-CoV-2 infection, the novel coronavirus.


Peripheral Blood Mononuclear Cells from COVID-19 Patients

Whether you’re studying the pathology of COVID-19 or investigating potential vaccines or treatments, PBMC from confirmed COVID-19 patients are the best starting material for your research.

Following the global outbreak of COVID-19, our researchers quickly and safely began collecting peripheral blood cells and plasma from donors with a history of SARS-CoV-2 infection.

Our COVID-19 PBMC are:

  • Confirmed to be antibody positive
  • Confirmed to be virus negative
  • Matched with serum or plasma from the same donor upon request



Some of our COVID-19 donors have undergone leukapheresis collections, so we have many vials available for bulk purchase or repeat purchase.


Related Products: COVID-19-Specific T Cells Available, COVID-19 Plasma Available


Note that as with any of our human blood products, we recommend cautious handling following all biosafety level 2 procedures. See a list of frequently asked questions about our COVID donors below.

How do you confirm a patient’s positive COVID-19 test?
All convalescent donors must provide proof of a positive laboratory diagnostic test for COVID-19.

How do you report on donor infection and recovery status?
The “time since infection” and “time since negative results” are recorded for each product as well as the neutralization titer information.

Are your COVID donors screened for other pathogens?
Yes. All donors undergo standard blood tests required for any blood donation. Additionally, convalescent COVID-19 donors must have an acceptable health history, pass a physical assessment, and undergo a COVID-19 antibody blood test to confirm status.

What collection protocol do you use?
We follow an IRB-approved protocol to support the research, therapeutic, and vaccine communities with much needed access to blood products collected from COVID-19 convalescent donors.

Where are convalescent COVID-19 collections performed?
In our Lowell, MA and Memphis, TN locations.

How do you ensure safety during collection?
All in-person activities include CDC recommended screening and social distancing measures for donor protection. All donors must be recovered, may not be taking any medications for COVID-19, and must be officially out of quarantine.

View our Researcher’s Guide to PBMC to learn more about the opportunities with human PBMC and tips for working with these vital cells.

Best of luck in your SARS-CoV-2 research endeavors. If you need any support or have research questions, ask one of our scientists and get a quick response.


Not Back in the Lab Yet?

Contact us to reserve your COVID-19 PBMC for when you’re back to work.

Leave a Reply

Your email address will not be published. Required fields are marked *

Post comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.